GSK plc - Jan 23, 2023 Form 3 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
10%+ Owner
Signature
Victoria Whyte, Authorized Signatory, GSK plc
Stock symbol
WVE
Transactions as of
Jan 23, 2023
Transactions value $
$0
Form type
3
Date filed
1/30/2023, 03:34 PM
Previous filing
Nov 14, 2022
Next filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding WVE Ordinary Shares 10.7M Jan 23, 2023 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").